Bottom line
RLGCX vs SBIO: the short answer
RLGCX (ALPS Asset Allocation Growth & Income) and SBIO (ALPS Medical Breakthroughs ETF) are both mutual funds.
But SBIO is far broader, holding 89 positions to 15 for RLGCX, so beyond the top names it adds exposure RLGCX doesn't have.
SBIO is cheaper at 0.5% vs 1.55% — a difference of $105 a year per $10,000 invested.
Over five years, RLGCX returned +6.2% a year vs +0.7% for SBIO.
Updated Nov 19, 2026
RLGCX vs SBIO side by side
| RLGCX | SBIO | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | American Funds (Capital Group) | Alps |
| Category | Allocation / Balanced | Health Care Sector |
| Expense ratio | 1.55% | 0.5% |
| Annual cost per $10k | $155 | $50 |
| 10-yr cost on $10k (prospectus) | $1,843 | $628 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | — |
| 1-yr return | +12.5% | +54.2% |
| 5-yr return (annualized) | +6.2% | +0.7% |
| 10-yr return (annualized) | +6.2% | +5.7% |
| Best quarter | — | +33.9% |
| Worst quarter | — | −30.8% |
| Net assets (fund) | $76.4M | $161.8M |
| Number of holdings | 15 | 89 |
| Portfolio turnover | 113% | 58% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
RLGCX and SBIO share none of their top holdings.
RLGCX top 10
- Alps Dynamic Us Dividend Advantage Etf — 19.59%
- Alps Active Equity Opportunity Etf — 19.34%
- Alps Strategic Income Fund — 12.54%
- Ishares Core Msci International Developed Markets Etf — 10.01%
- Vanguard Morningstar Total Stock Market Etf — 6.07%
- Ishares Core U.s. Aggregate Bond Etf — 5.26%
- Alps International Sector Dividend Dogs Etf — 5.07%
- Ishares Core S&p 500 Etf — 4.26%
- Alps Electrification Infrastructure Etf — 3.89%
- Vanguard Mortgage-backed Securities Etf — 3.64%
SBIO top 10
- Alkermes Plc — 4.48%
- Kymera Therapeutics Inc — 4.23%
- Celcuity Inc — 3.92%
- Mirum Pharmaceuticals Inc — 3.90%
- Spyre Therapeutics Inc — 3.68%
- Cg Oncology Inc — 3.35%
- Apogee Therapeutics Inc — 2.93%
- Xenon Pharmaceuticals Inc — 2.90%
- Travere Therapeutics Inc — 2.77%
- Dianthus Therapeutics Inc — 2.64%
FAQ
What is the difference between RLGCX and SBIO?
RLGCX (ALPS Asset Allocation Growth & Income) and SBIO (ALPS Medical Breakthroughs ETF) are both mutual funds. But SBIO is far broader, holding 89 positions to 15 for RLGCX, so beyond the top names it adds exposure RLGCX doesn't have.
Which is cheaper, RLGCX or SBIO?
SBIO has the lower expense ratio (0.5%).
Should I own both RLGCX and SBIO?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.